What are the 4 key criteria to address when trying to validate a drug target?

Question

BlackTom AI · Accepted Answer

Biological relevance, druggability, assayability, and safety are the four essential criteria for validating a drug target.

1) Relevant knowledge points and concepts
- Biological relevance: the target must play a causal, modifiable role in the disease mechanism (genetic, pathway, or phenotypic evidence).  
- Druggability: the target must have structural or biochemical features that allow a small molecule or biologic to bind and alter its function with reasonable potency.  
- Assayability: robust, reproducible assays must exist (or be developed) to measure target modulation in vitro and in cells for screening and optimization.  
- Safety (safety window): target modulation should not cause unacceptable on‑target or predictable off‑target toxicities; ideally, human genetics or animal models suggest tolerability.

2) Step‑by‑step reasoning
- Step 1: Establish biological relevance via genetic association, disease models, expression patterns, or pathway analyses; without this, modulating the target won’t affect disease.  
- Step 2: Assess druggability by evaluating target class (enzymes, GPCRs, ion channels are classically druggable), presence of ligandable pockets, or feasibility of antibody approaches.  
- Step 3: Confirm assayability by developing biochemical or cell‑based readouts to screen and quantify target engagement and downstream effects.  
- Step 4: Evaluate safety risks using genetics, knockout phenotypes, and early toxicology to estimate a therapeutic window.

3) Calculations/intermediate steps
- Not applicable for conceptual criteria; reasoning proceeds qualitatively through evidence evaluation.

4) Why the correct answer is correct
- These four criteria directly address whether a target can be linked to disease, modulated by a drug, measured for discovery, and modulated safely—covering the core go/no‑go decisions when validating targets.

5) Why other options are incorrect
- (a) Clinical efficacy, cost, manufacturability, regulatory approval are downstream, post‑target validation concerns.  
- (c) Pharmacokinetics, efficacy, toxicity, metabolism are properties of candidate drugs, not initial target validation.  
- (d) Selectivity, potency, stability, formulation describe compound attributes during lead optimization, not the target itself.

Conclusion: Option b (Biological relevance, druggability, assayability, and safety) is the correct answer and matches the provided answer.

What are the 4 key criteria to address when trying to validate a drug target?单项选择题

类似问题

What are the 4 key criteria to address when trying to validate a drug target?在验证药物靶点时，需要解决的四个关键标准是什么？

What was the world's first widely adopted biodiversity policy?

The aim of the Paris Agreement is to ensure that the earth’s preindustrial temperature is not exceeded by more than º Celsius.

The IPCC's mission is to Blank ______.

Why have most international agreements for environmental protection been based on the honor system?

As was exhibited with the Montreal Protocol and the encouragement of reduced CFC production, trade can be an effective tool to compel compliance with international treaties.

The Stockholm Declaration and UNEP were the result of the Blank ______ first conference on the Human Environment in 1972.

In addition to the direct mission of the Convention on International Trade in Endangered Species (CITES), why was CITES so important?

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单